Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA Gene

NCT06814431 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.

NCT NCT06814431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06814431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA Gene
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Observational
Overall status
Recruiting
Start date
November 23, 2023
Completion date
December 31, 2026
Enrollment
3,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic parkinson's disease (pd)